Along with genomics, tissue phenomics is driving the growth of personalized medicine and impacting how novel cancer treatments are discovered, validated, and commercialized. The International Symposium for Tissue Phenomics will feature thought leaders on companion diagnostics, immunotherapy, and tissue-based patient stratification for personalized medicine. Presentations will include pragmatic approaches to development of companion diagnostics, analysis of data, and validation of assays used to drive therapies. Speakers will include industry leaders from organizations such as OncoMed Pharmaceuticals, MedImmune, Frederick National Laboratory for Cancer Research, Kimmel Cancer Center, and University Medical Center Heidelberg.